You should read more about the journey from novel molecule (basic science, generally publicly funded research) to a commercialized drug.
It is obscenely hard, expensive, and risky to get a drug — even one that works really well — to market. It’s much harder when you factor in lack of knowledge ahead of time about which molecules in your portfolio actually work.
IMO there should be some structure for taxpayers/grant funding agencies to get paid royalties on successful drug programs, but you wildly wildly misunderstand what the hard parts of drug development are.
It’s not publishing papers about molecules that do things in Petri dishes.
It is obscenely hard, expensive, and risky to get a drug — even one that works really well — to market. It’s much harder when you factor in lack of knowledge ahead of time about which molecules in your portfolio actually work.
IMO there should be some structure for taxpayers/grant funding agencies to get paid royalties on successful drug programs, but you wildly wildly misunderstand what the hard parts of drug development are.
It’s not publishing papers about molecules that do things in Petri dishes.